HOME > TOP STORIES
TOP STORIES
-
BUSINESS VLP Therapeutics Eyes Japan Filing of Next-Gen mRNA Vaccine in Mid-2024: CEO
October 31, 2023
-
REGULATORY No Objections to Reflecting Company Indices for Generic Supplies in Pricing: Chuikyo
October 30, 2023
-
REGULATORY Medical, Long-Term Care Data Linkage Holds Key to CEA: Leqembi Debate
October 30, 2023
-
BUSINESS Merck Sues Sawai over Januvia Generics Approved in Japan
October 27, 2023
-
ORGANIZATION Chuikyo Rep Interview 3-2 - Rengo Wants Substantive Discussions on Pricing System, Off-Year Revisions over Next Few Years
October 26, 2023
-
BUSINESS With Wholesalers Narrowed Down, Hospitals Face Squeezed Discounts for GSK Products
October 25, 2023
-
ORGANIZATION Chuikyo Rep Interview 3-1 - Rengo Seeks Patient-Centric Debate, Sees Exhausted Wholesalers as Big Issue
October 25, 2023
-
BUSINESS Sawai Fudged Quality Tests of Gastritis Drug for 8 Years, Awaiting Penalty Decision
October 24, 2023
-
BUSINESS Daiichi Sankyo, Merck in Global ADC Deal Worth Up to US$22 Billion
October 23, 2023
-
REGULATORY Chuikyo Wants Sakigake Premium Review as a Package with Regulatory Reform
October 23, 2023
-
BUSINESS Medicon, Mucodyne among Drugs Subject to MHLW’s Ramp-Up Request
October 20, 2023
-
BUSINESS Oncology, Cell & Gene Therapies Key Priorities for Bayer Co.Labs: Global Head
October 20, 2023
-
REGULATORY China Formally Arrests Astellas Employee, Japan Urges Immediate Release
October 20, 2023
-
REGULATORY Japan to Buy 10 Million More Doses of Pfizer/Moderna COVID Jabs
October 19, 2023
-
REGULATORY Health Minister Requests 8 Makers to Bolster Supplies of Antitussive, Expectorant Agents
October 19, 2023
-
REGULATORY Chuikyo at Odds over Handling of Startups in PMP, Timing of Deferred Price Cuts
October 19, 2023
-
BUSINESS BMS Looks to Double Japan Biz in Next 10 Years with Partnership as a Pillar
October 19, 2023
-
REGULATORY Average Price Gap for 2024 Revision Looks to Be Lower than 7.0%: Wholesalers
October 18, 2023
-
BUSINESS IBM Leads Development of Integrated Drug Supply Database for Wholesaler Reps, Pharmacists
October 18, 2023
-
REGULATORY AMED Group to Draft Master Protocols Guidelines by March-End, Frets Further Drug Lag/Loss
October 17, 2023
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
